Modulation of IL-12/IL-23 signaling pathways by ustekinumab alleviates inflammation in Crohn’s disease patients
Review articleGastroent Hepatol 2018; 72(4): 334–339. doi:10.14735/amgh2018334
SummaryLiteraturepdf Jan KrejsekGastroent Hepatol 2018; 72(4): 334–339. doi:10.14735/amgh2018334
SummaryLiteraturepdf Jan Krejsek